After years of easily available, cheap copies of Eli Lilly's and Novo Nordisk's highly effective weight-loss drugs, some U.S. patients say they are unwilling to pay more and are pursuing alternatives to get around the regulatory deadline for compounding pharmacies to stop making them.

Trump’s proposed tariffs on imported pharmaceuticals aim to boost U.S. manufacturing but may cause drug shortages and higher costs, raising concerns of a healthcare crisis

Pharmaceutical tariffs could increase drug prices and drug shortages, negatively impacting the health care system, experts warn.

Generics maker Sandoz says president should focus on tactic of ‘evergreening’ pricier products in his drive to lower costs

In the dim basement of a Salt Lake City pharmacy, hundreds of amber-colored plastic pill bottles sit stacked in rows, one man's defensive wall in a tariff war.

Incorporating emerging technologies like AI in the drug production process has the potential to boost manufacturing efficiency, lower costs, curb drug shortages ... hops on the US investment ...

The U.S. Food and Drug Administration has cracked down on compounded drugs, which were readily available while the patented ones were in shortage, and many are worried they will lose access to the treatments that have given them hope and changed their lives, according to interviews with 10 patients.

Novo Nordisk A/S is selling its blockbuster weight-loss drug Wegovy to new patients at $199 for the first month as easy access to cheaper copycats comes to an end.